Recombinant SARS-CoV-2 Virus-Like Particles produced in insect SF9 cells or mammalian HEK293 cells. VLPs consist of different combinations of N, M, E and S structural proteins of SARS-CoV-2 , transiently expressed to form a nanoparticle. VLPs do not contain non-structural proteins or genome and are non-infectious.
Available combinations:
N -VLP
N+M+E- VLP
N+M+E+S -VLP